A new blood test could speed up diagnosis and treatment for people dealing with early memory or thinking changes. The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to ...

A simple blood test might detect women at risk for cognitive decline and dementia 25 years before any symptoms appear. The blood test looks for high levels of a protein called p-tau217, indicating ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." According to the NIH, Alzheimer's disease accounts for up to two-thirds of dementia cases in people 65 ...

An integrated suite of bioassays provides a coherent workflow to track antibody Fc effector activity across every stage of mAb drug development Potency assays that fail during tech transfer or ...

In a nutshell: As the global population ages, Alzheimer's disease has become one of the most common forms of dementia affecting older adults. Traditional diagnostic methods are often expensive and ...

A new study conducted by Washington University School of Medicine in St. Louis researchers found that a single blood test could predict when someone is likely to develop Alzheimer’s disease. The study ...

Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...

Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...

When it comes to cancer, waiting for symptoms may soon be old news. Telehealth company Hims & Hers began offering a blood test this week that screens for a wide range of cancers before warning signs ...

Cell and gene therapies (CGTs) are shaping modern medicine by targeting diseases at their source through cellular and genetic modifications. The true game-changer for such therapies will lie in ...